The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2022 1
2021 2
2020 1

U.S. 1
United States 1

Journal Article 5

1 - 5 of 5 Results

Refine Results

Refine Results:

Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data

CITE Title : Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data Personal Author(s) : Nelson, Jennifer C.;Ulloa-Pérez, Ernesto;Yu, Onchee;Cook, Andrea J.;Jackson, Michael L.;Belongia, Edward A.;Daley, Matthew F.;Harpaz, Rafael;Kharbanda, Elyse O.;Klein, Nicola P.;Naleway, Allison L.;Tseng, Hung-Fu;Weintraub, Eric S.;Duffy, Jonathan;Yih, W. Katherine;Jackson, Lisa A.; Published Date : 10 04 2022;2-01-; Source : Am J Epidemiol. 192(2):205-216 URL : https://stacks.cdc.gov/view/cdc/124323 Nelson, Jennifer C. et al. (2022). Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data. 192(2). Nelson, Jennifer C. et al. "Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data" 192, no. 2 (2022) Nelson, Jennifer C. et al. "Active Postlicensure Safety Surveillance for Recombinant Zoster Vaccine Using Electronic Health Record Data" vol. 192, no. 2, 2022 Export RIS Citation Information.

:

Nelson, Jennifer C. ;

Ulloa-Pérez, Ernesto

10 04 2022 | Am J Epidemiol. 192(2):205-216

:

Recombinant zoster vaccine (RZV) (Shingrix; GlaxoSmithKline, Brentford, United Kingdom) is an adjuvanted glycoprotein vaccine that was licensed in 201...
Mortality risk after COVID-19 vaccination: A self-controlled case series study

CITE Title : Mortality risk after COVID-19 vaccination: A self-controlled case series study Personal Author(s) : Xu, Stanley;Sy, Lina S.;Hong, Vennis;Farrington, Paddy;Glenn, Sungching C.;Ryan, Denison S.;Shirley, Abraelle M.;Lewin, Bruno J.;Tseng, Hung-Fu;Vazquez-Benitez, Gabriela;Glanz, Jason M.;Fireman, Bruce;McClure, David L.;Hurley, Laura P.;Yu, Onchee;Wernecke, Michael;Smith, Ning;Weintraub, Eric S.;Qian, Lei; Published Date : 3-07- Source : Vaccine. 42(7):1731-1737 URL : https://stacks.cdc.gov/view/cdc/158686 Xu, Stanley et al. (2024). Mortality risk after COVID-19 vaccination: A self-controlled case series study. 42(7). Xu, Stanley et al. "Mortality risk after COVID-19 vaccination: A self-controlled case series study" 42, no. 7 (2024) Xu, Stanley et al. "Mortality risk after COVID-19 vaccination: A self-controlled case series study" vol. 42, no. 7, 2024 Export RIS Citation Information.

:

Xu, Stanley ;

Sy, Lina S.

3-07- | Vaccine. 42(7):1731-1737

:

Background:Although previous studies found no-increased mortality risk after COVID-19 vaccination, residual confounding bias might have impacted the f...
Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus

CITE Title : Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus Personal Author(s) : Jensen, Nancy J.;Depledge, Daniel P.;Ng, Terry F.;Quinlivan, Mark;Radford, Kay W.;Folster, Jennifer;Tseng, Hung-Fu;LaRussa, Philip;Jacobsen, Steven J.;Breuer, Judith;Schmid, D. Scott; Published Date : 7 2020;7-2020; Source : Virology. 546:38-50 URL : https://stacks.cdc.gov/view/cdc/119227 Jensen, Nancy J. et al. (2020). Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus. 546 Jensen, Nancy J. et al. "Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus" 546 (2020) Jensen, Nancy J. et al. "Analysis of the reiteration regions (R1 to R5) of varicella-zoster virus" vol. 546, 2020 Export RIS Citation Information.

:

Jensen, Nancy J. ;

Depledge, Daniel P.

7 2020 | Virology. 546:38-50

:

The varicella-zoster virus (VZV) genome, comprises both unique and repeated regions. The genome also includes reiteration regions, designated R1 to R5...
COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, U.S. December 14, 2020–July 31, 2021

CITE Title : COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, U.S. December 14, 2020–July 31, 2021 Personal Author(s) : Xu, Stanley;Huang, Runxin;Sy, Lina S.;Glenn, Sungching C.;Ryan, Denison S.;Morrissette, Kerresa;Shay, David K.;Vazquez-Benitez, Gabriela;Glanz, Jason M.;Klein, Nicola P.;McClure, David;Liles, Elizabeth G.;Weintraub, Eric S.;Tseng, Hung-Fu;Qian, Lei; Published Date : 10 29 2021 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 70(43):1520-1524 DOI : http://dx.doi.org/10.15585/MMWRmm7043e2 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Xu, Stanley et al. (2021). COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, U.S. December 14, 2020–July 31, 2021. 70(43). http://dx.doi.org/10.15585/MMWRmm7043e2 Xu, Stanley et al. "COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, U.S. December 14, 2020–July 31, 2021" 70, no. 43 (2021), http://dx.doi.org/10.15585/MMWRmm7043e2 Xu, Stanley et al. "COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, U.S. December 14, 2020–July 31, 2021" vol. 70, no. 43, 2021, http://dx.doi.org/10.15585/MMWRmm7043e2 Export RIS Citation Information.

:

Xu, Stanley ;

Huang, Runxin

10 29 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

By September 21, 2021, an estimated 182 million persons in the U.S. were fully vaccinated against COVID-19.* Clinical trials indicate that Pfizer-BioN...
COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021

CITE Title : COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021 Personal Author(s) : Xu, Stanley;Huang, Runxin;Sy, Lina S.;Glenn, Sungching C.;Ryan, Denison S.;Morrissette, Kerresa;Shay, David K.;Vazquez-Benitez, Gabriela;Glanz, Jason M.;Klein, Nicola P.;McClure, David;Liles, Elizabeth G.;Weintraub, Eric S.;Tseng, Hung-Fu;Qian, Lei; Corporate Authors(s) : Kaiser-Permanente Medical Care Program. Southern California Region. Research and Evaluation.;CDC COVID-19 Response Team.;HealthPartners Institute (Minneapolis, Minnesota);Institute for Health Research (Kaiser Permanente Colorado);Kaiser Permanente Vaccine Study Center.;Marshfield Clinic Research Institute.;Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region);National Center for Emerging and Zoonotic Infectious Diseases (U.S.)Immunization Safety Office.; Published Date : October 22, 2021 Pages in Document : 6 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2021; v. 70 Early Release URL : https://stacks.cdc.gov/view/cdc/110989 Xu, Stanley et al. (2021). COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021. 70 Xu, Stanley et al. "COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021" 70 (2021) Xu, Stanley et al. "COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021" vol. 70, 2021 Export RIS Citation Information.

:

Xu, Stanley ;

Huang, Runxin

October 22, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Although deaths after COVID-19 vaccination have been reported to the Vaccine Adverse Events Reporting System, ...